​

Creative Medical Technology Stock (NASDAQ:CELZ)

RevenueOwnershipFinancialsChart

Previous Close

$2.11

52W Range

$1.50 - $6.25

50D Avg

$2.22

200D Avg

$2.52

Market Cap

$5.50M

Avg Vol (3M)

$58.07K

Beta

1.83

Div Yield

-

CELZ Company Profile

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Nov 06, 2015

Website

CELZ Performance

CELZ Financial Summary

Dec 25Dec 24Dec 23
Revenue$6.00K$11.00K$9.00K
Operating Income$-6.02M$-5.74M$-5.62M
Net Income$-6.00M$-5.49M$-5.29M
EBITDA$-6.02M$-5.63M$-5.53M
Basic EPS$-2.52$-3.71$-3.76
Diluted EPS$-2.52$-3.71$-3.76

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
ALZNAlzamend Neuro, Inc.
HCWBHCW Biologics Inc.
ADXNAddex Therapeutics Ltd
ACXPAcurx Pharmaceuticals, Inc.
KPRXKiora Pharmaceuticals, Inc.
ADILAdial Pharmaceuticals, Inc.
PHIOPhio Pharmaceuticals Corp.
APREAprea Therapeutics, Inc.
BCDABioCardia, Inc.
CDIOCardio Diagnostics Holdings, Inc.